About Enrich Biosystems
Enrich Biosystems is a private company based in Branford, Connecticut. It has reported $8,216,765 raised in four offerings on Form D since June 2022. Its chief executive is Dong Wang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Nov 26, 2025 | $1,450,000of $1.5M target | 4 | $362K | DebtRule 506(b) | Form D ↗ |
| May 3, 2024 | May 20, 2024 | $750,000fully sold | 10 | $75,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 3, 2024 | May 20, 2024 | $2,241,765of $3.1M target | 17 | $131K | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 16, 2022 | Jun 3, 2022 | $3,775,000of $4.0M target | 26 | $145K | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $8,216,765 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Enrich Biosystems's Form D filed Nov 26, 2025.
DW
Daniel Wagner
Director
QZ
Qi Zhao
Executive officer and director
CM
Christopher McLeod
Director
DW
Dong Wang
Chief Executive Officer and director
JT
Jay Teich
Director
Earlier filings also listed Cynthia Green (director, last listed May 2024).